Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 4

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 4
---
    8-K
    001-38957
    10.2
    8/7/2019

    19
    Insider Trading Policies and Procedures
    X

    21.1
    List of Subsidiaries
     
    10-K
    001-38957
    21.1
    2/14/2023

    23.1
    Consent of Independent Registered Public Accounting Firm
    X

    24.1
    Power of Attorney (included on the signature page)
    X

    31.1
    Certification of Principal Executive Officer pursuant to Rule 13a‑14(a) or Rule 15d‑14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    X

    31.2
    Certification of Principal Financial Officer pursuant to Rule 13a‑14(a) or Rule 15d‑14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    X

126

    Incorporated by Reference

    ExhibitNumber
    Exhibit Title
    Filed/FurnishedWith ThisReport
    Form
    File No.
    Exhibit
    Filing Date

    32.1
    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    X

    32.2
    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    X

    97.1*
    Adaptive Biotechnologies Corporation Policy for the Recovery of Erroneously Awarded Compensation
     
    10-K
    001-38957
    97.1
    2/29/2024

    101.INS
    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
    X

    101.SCH
    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
    X

    104
    Cover Page